DDTPA   Click here for help

GtoPdb Ligand ID: 12967

Synonyms: compound 74 [PMID: 33540044]
Compound class: Synthetic organic
Comment: DDTPA is an orally bioavailable P2X3 ion channel antagonist [1]. It is an analogue of the clinical lead sivopixant (S-600918). DDTPA exhibits higher affinity and high selectivity for hP2X3 homotrimeric ATP-gated ion channels compared to hP2X2/3 heterotrimeric channels in vitro. DDTPA appears to have an allosteric mode of action [2]. This compound was not considered as a clinical candidate due to the predicted high dose required in humans to produce the pharmacodynamic effect. It provides a suitable P2X3 selective tool for in vitro experiments and non-primate animal model studies.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 111.54
Molecular weight 472.92
XLogP 2.61
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C)OC1=CC=C(C=C1Cl)NC2=NC(=O)N(CCC(=O)O)C(=O)N2CC3=CC=C(C)C=C3
Isomeric SMILES ClC=1C=C(C=CC1OC(C)C)NC=2N(C(N(C(N2)=O)CCC(=O)O)=O)CC3=CC=C(C=C3)C
InChI InChI=1S/C23H25ClN4O5/c1-14(2)33-19-9-8-17(12-18(19)24)25-21-26-22(31)27(11-10-20(29)30)23(32)28(21)13-16-6-4-15(3)5-7-16/h4-9,12,14H,10-11,13H2,1-3H3,(H,29,30)(H,25,26,31)
InChI Key KRHNDEFYSFIWAD-UHFFFAOYSA-N
References
1. Kai H, Horiguchi T, Kameyama T, Asahi K, Endoh T, Jikihara S, Hasegawa T, Tanaka S, Nozu A, Takeyama C et al.. (2021)
Dioxotriazine derivatives as a new class of P2X3 receptor antagonists: Identification of a lead and initial SAR studies.
Bioorg Med Chem Lett, 37: 127833. [PMID:33540044]
2. Wang DP, Zhang M, Li M, Yang XN, Li C, Cao P, Zhu MX, Tian Y, Yu Y, Lei YT. (2024)
Druggable site near the upper vestibule determines the high affinity and P2X3 homotrimer selectivity of sivopixant/S-600918 and its analogue DDTPA.
Br J Pharmacol, 181 (8): 1203-1220. [PMID:37921202]